SPONSOR
Shenzhen Geno-Immune Medical Institute
Total Trials
6
Recruiting
6
Phases
Phase 1, Phase 1, Phase 2
Conditions studied: Multiple Myeloma in RemissionT-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaAcute Myeloid LeukemiaNK Cell LymphomaB Cell MalignanciesOvarian CancerBladder CancerUrothelial Carcinoma BladderSolid Tumor
NCT06006741 Phase 1
Recruiting
Universal CAR-T Cells Targeting Multiple Myeloma
Multiple Myeloma in Remission
NCT05995028 Phase 1
Recruiting
Universal 4SCAR7U Targeting CD7-positive Malignancies
T-cell Acute Lymphoblastic Leukemia
NCT05432882 Phase 1, Phase 2
Recruiting
CD19/22 Bi-specific CAR-T Cell Therapy
B Cell Malignancies
NCT03184753 Phase 1, Phase 2
Recruiting
Genetically Modified T Cells Against Ovarian Cancer
Ovarian Cancer
NCT03185468 Phase 1, Phase 2
Recruiting
Intervention of Bladder Cancer by CAR-T
Bladder Cancer
NCT02992210 Phase 1, Phase 2
Recruiting
Study on GD2 Positive Solid Tumors by 4SCAR-GD2
Solid Tumor